Impact of age on treatment and outcomes after acute myocardial infarction, particularly in very elderly patients;Impacto da idade no tratamento e resultados após enfarte agudo do miocárdio em particular nos muito idosos

Revista Portuguesa de Cardiologia

Volumn 30, Issue 12, 2011, Pages 897-903

  Timóteo, Ana Teresa ^a   Ramos, Ruben ^a   Toste, Alexandra ^a   Lousinha, Ana ^a   Oliveira, José Alberto ^a   Ferreira, Maria Lurdes ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Acute myocardial infarction; Age; Elderly; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PREDICTOR VARIABLE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84856460028     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2011.09.013     Document Type: Article

References (12)

1. Haase KK, Schiele R, Wagner S, et al. In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA Registry. Clin Cardiol. 2000;23:831-6.
2. Sala J, Marrugat J, Masia R, et al. Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. Eur Heart J. 1995;16:779-84.
3. Avezum A, Makdisse M, Spencer F, et al. Impact of age on management and outcome of acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005;149:67-73. (Pubitemid 40126492)
4. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for under-treatment in women and the elderly. Arch Int Med. 1996;156:799-885.
5. Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol. 1995;25:1327-32.
6. Gurwitz JH, Gore JM, Goldberg RJ, et al. Recent age-related trends in the era of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996;124:283-91. (Pubitemid 26047453)
7. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed dose and outcome. Ann Intern Med. 1996;124:292-8. (Pubitemid 26047454)
8. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669-77.
9. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction. The CAPRICORN randomised trial. Lancet. 2001;357:1385-90. (Pubitemid 32455364)
10. Cannon CP, McCabe CH, Belder R, et al. Intensive versus mode-rate lipid lowering with statins after acute coronary syndromes (PROVE IT - TIMI 22 trial). N Engl J Med. 2004;350:1495-504. (Pubitemid 38477774)
11. OASIS Registry InvestigatorsYusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998;352:507-14.
12. Montoye CK, Eagle KA. An organizational framework for the AMI ACC-GAP Project. J Am Coll Cardiol. 2005;46 Suppl B:1B-29B.